{
  "$schema": "folio-library-entry/v1",
  "id": "10665-372197",
  "blocks": [
    {
      "id": "library/10665-372197/blocks/prose-sec-front-matter",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Front matter",
      "pageStart": 1,
      "pageEnd": 6,
      "target": "../sections/sec-front-matter.md",
      "narrative": null,
      "content": "2022\n6-MONTH \nREPORT\n12-MONTH \nREPORT\n18-MONTH \nREPORT\n24-MONTH \nREPORT\n2023\nPandemic \nInﬂuenza \nPreparedness \nFramework\nAnnual \nprogress \nreport\n1 January – \n31 December\n2022\nPandemic Influenza \nPreparedness Framework\nAnnual Progress Report\n1 January – 31 December 2022\nPandemic Influenza Preparedness Framework: annual progress report, 1 January – 31 December 2022\nISBN 978-92-4-007690-7 (electronic version)\nISBN 978-92-4-007691-4 (print version)\n© World Health Organization 2023\nSome rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The front matter of the Pandemic Influenza Preparedness (PIP) Framework annual progress report for 2022, with the cover, ISBN and copyright page under a CC BY-NC-SA 3.0 IGO licence. It also contains the contents and a list of acronyms used in the report.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-372197/blocks/prose-sec-000",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Acronyms & abbreviations",
      "pageStart": 6,
      "pageEnd": 7,
      "target": "../sections/sec-000-acronyms-abbreviations.md",
      "narrative": null,
      "content": "Acronyms & abbreviations",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A heading page for the list of acronyms and abbreviations.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-372197/blocks/prose-sec-001",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Introduction",
      "pageStart": 7,
      "pageEnd": 9,
      "target": "../sections/sec-001-introduction.md",
      "narrative": null,
      "content": "Member States, industry, other stakeholders and WHO to implement a global approach to pandemic influenza preparedness \nand response. The key goals include: to improve and strengthen the sharing of influenza viruses with human pandemic \npotential through the WHO Global Influenza Surveillance and Response System (GISRS), and to increase the access of \ndeveloping countries to vaccines and other pandemic response supplies.\nThe Framework includes a benefit-sharing mechanism called the Partnership Contribution (PC). The PC is collected as an annual \ncash contribution from influenza vaccine, diagnost",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Introduces the Pandemic Influenza Preparedness Framework, which aims to improve sharing of influenza viruses with pandemic potential through WHO's GISRS network and to widen developing countries' access to vaccines and other supplies. It explains the Partnership Contribution, an annual payment by manufacturers that use GISRS, and how it funds preparedness capacity building, pandemic response and the PIP Secretariat, and thanks the staff who carry out the work.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-372197/blocks/prose-sec-002",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "PIP Framework implementation overview",
      "pageStart": 9,
      "pageEnd": 12,
      "target": "../sections/sec-002-pip-framework-implementation-overview.md",
      "narrative": null,
      "content": "implementation \noverview\nPIP PC collection (As of 31 December 2022)\nPERCENTAGE OF TOTAL PC RECEIVED FROM CONTRIBUTORS\n$282.9M\nCONTRIBUTED BY \nINDUSTRY b\nMILLION US$\n2012 a\n30\n25\n20\n15\n10\n5\n0\nTARGET\n28M\n/YEAR\n2013\n2014\n2015\n2016\n2017\n2018\n2019\n2020\n2021\n2022\n99%\n97%\n98%\n97%\n97%\n97%\n97%\n98%\n97%\n68%\na In 2012, contributions were made voluntarily.\nb Figure includes PSC. PC collection for previous unpaid contributions and 2022 invoices is in process. Invoices for 2022 \nissued end of June 2022. The figure does not include interest earned on Response Funds of $ 4.01 million in 2018-2022.\nPIP PC finan",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Gives an overview of PIP Framework implementation to the end of 2022, with infographics on Partnership Contribution collection, totalling about US$ 282.9 million from industry, and yearly collection rates against a US$ 28 million target. It also reports the 2022–2023 budgets, funding and spending for preparedness, response and the secretariat, and progress on agreements with manufacturers to secure pandemic products.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-372197/blocks/prose-sec-003",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Technical and financial implementation progress",
      "pageStart": 12,
      "pageEnd": 14,
      "target": "../sections/sec-003-technical-and-financial-implementation-progress.md",
      "narrative": null,
      "content": "implementation \nprogress\nOUTPUT READING GUIDE\nNOTE TO READERS\nPlease read this Output Reading Guide which \nprovides clarity on the data reported in this section.\nOutput name & statement\nFunds implemented \ncumulatively at \ndeliverable level\n(excluding PSC)\nIndicators: progress \nupdated annually. \nResults are presented \nagainst biennial targets\n(Baselines are as of\n31 December 2017)\nProportion of funds implemented \nfrom the biennial budget \n(gray denotes proportion of funds \nnot implemented)\nDeliverable name\nBiennial budget & funds implemented \ncumulatively at Output level \n(excluding PSC)\nHighl",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A reading guide explaining how the following output pages present budgets, funds implemented, highlights, milestones and indicators, shown as a template with placeholder values.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-372197/blocks/prose-sec-004",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Laboratory & surveillance",
      "pageStart": 14,
      "pageEnd": 16,
      "target": "../sections/sec-004-laboratory-surveillance.md",
      "narrative": null,
      "content": "BIENNIAL BUDGET:\nOUTPUT: National influenza L&S systems contribute to GISRS for timely risk assessment & response measures\nIMPLEMENTED:\n$18.2M\n$6.5M\nDELIVERABLE A\nDELIVERABLE B\nDELIVERABLE C\nMILESTONES\nMILESTONES\nMILESTONES\nIMPLEMENTED\n$2M\nIMPLEMENTED\n$2.1M\nIMPLEMENTED\n$954K\nHIGHLIGHTS\nHIGHLIGHTS\nHIGHLIGHTS\nRisk and severity \nof influenza, \nincluding at the \nhuman-animal \ninterface, are \nroutinely assessed\nQuality influenza \nvirus detection \ncapacity is \nsustained\nCountries are \nsupported to \nconsistently report \ninfluenza data to \nglobal platforms\n•\tRisk and severity assessments are critical",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Reports 2022 progress on the laboratory and surveillance output, which supports national influenza systems contributing to GISRS, with its budget and spending by deliverable. Highlights include ten published risk assessments at the human-animal interface, countries reporting severity assessments, training on virus detection and reporting of influenza data to global platforms. Indicators track timely sharing of viruses and specimens with WHO collaborating centres.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-372197/blocks/prose-sec-005",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Burden of disease",
      "pageStart": 16,
      "pageEnd": 17,
      "target": "../sections/sec-005-burden-of-disease.md",
      "narrative": null,
      "content": "BIENNIAL BUDGET:\nOUTPUT:\nDELIVERABLE A\nDELIVERABLE B\nMILESTONE\nMILESTONE\nIMPLEMENTED\n$120K\nIMPLEMENTED\n$211K\nHIGHLIGHTS\nHIGHLIGHTS\nNumber of countries in each burden \nof disease estimate development \nstage (N=194)\nRepresentative \nnational, regional \nand global disease \nburden estimates \nare available\nDisease burden \nfindings are \ncommunicated \nto national and \ninternational expert \nbodies in a format \nthat promotes \nevidence-based \ndecision making\nInfluenza disease burden estimates are used for public health decisions\nIMPLEMENTED:\n$1.4M\n$331K\n•\tIn 2022, two additional countries published their",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Reports progress on influenza burden of disease work, noting that 50 countries, most of them lower-middle-income, had published estimates by 2022 and others planned to calculate them. It also tracks the use of estimates in policy and development of a tool to estimate burden across the severity spectrum.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-372197/blocks/prose-sec-006",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Regulatory capacity building",
      "pageStart": 17,
      "pageEnd": 18,
      "target": "../sections/sec-006-regulatory-capacity-building.md",
      "narrative": null,
      "content": "BIENNIAL BUDGET:\nOUTPUT:\nDELIVERABLE A\nDELIVERABLE B\nMILESTONES\nMILESTONES\nIMPLEMENTED\n$599K\nIMPLEMENTED\n$623K\nHIGHLIGHTS\nHIGHLIGHTS\nRefinements made \nto WHO GBT\nCountries WHO-benchmarked\nCountries self-benchmarked\nIDP follow-up \nvisits\nNational regulatory \ncapacity for \npandemic influenza \nproducts is \nstrengthened\nAdoption of \nregulatory \npathways that \naccelerate approval \nfor use of pandemic \ninfluenza products \nis promoted\nTimely access to quality-assured influenza pandemic products is supported\nIMPLEMENTED:\n$2.5M\n$1.2M\n•\tIn 2022, seven countries increased their \nemergency regulatory capa",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Reports progress on regulatory capacity building for pandemic influenza products, including countries that improved emergency regulatory preparedness after WHO benchmarking, self-benchmarking assessments and WHO workshops. It also tracks adoption of fast-track approval pathways and an update of WHO's regulatory preparedness guideline.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-372197/blocks/prose-sec-007",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Risk communications & community engagement",
      "pageStart": 18,
      "pageEnd": 19,
      "target": "../sections/sec-007-risk-communications-community-engagement.md",
      "narrative": null,
      "content": "BIENNIAL BUDGET:\nOUTPUT: Tools and guidance are available for countries to enhance influenza risk communication and \ncommunity engagement\nIMPLEMENTED:\n$2.2M\n$597K\nDELIVERABLE A\nCountries and frontline \nresponders have \naccess to resources \nfor influenza risk \ncommunication, \ncommunity \nengagement and \nsocial science-based \ninterventions\nTechnical assistance \nis provided to \ncountries to plan and \nexercise influenza risk \ncommunication and \ncommunity engagement\nIMPLEMENTED\n$338K\nIMPLEMENTED\n$259K\nDELIVERABLE B\nMILESTONE\nMILESTONES\nINDICATORS\nINDICATOR\nHIGHLIGHTS\nHIGHLIGHTS\n• WHO continues to wo",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Reports progress on influenza risk communication and community engagement, including work with WHO's EPI-WIN network on webinars with faith, youth and workplace communities and technical support to countries. Indicators cover a community platform and countries adapting a social listening approach for acute respiratory infections.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-372197/blocks/prose-sec-008",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Planning for deployment",
      "pageStart": 19,
      "pageEnd": 20,
      "target": "../sections/sec-008-planning-for-deployment.md",
      "narrative": null,
      "content": "BIENNIAL BUDGET:\nOUTPUT: Plans for effective & efficient deployment of pandemic supplies are optimized\nIMPLEMENTED:\n$1.6M\n$375K\nDELIVERABLE A\nDELIVERABLE B\nDELIVERABLE C\nIMPLEMENTED\n$170K\nIMPLEMENTED\n$0K\nIMPLEMENTED\n$205K\nA common approach \nto manage global \ndeployment operations is \ndeveloped and regularly \ntested with stakeholders \nand deployment partners\nNational deployment \nplanning process is \nrevised and updated\nTechnical assistance \nto develop policies for \nsustainable influenza \nvaccine procurement \nand production is \nprovided to countries\n71%\n29%\n100%\n82%\n18%\nHIGHLIGHTS\nHIGHLIGHTS\nHIG",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Reports progress on planning the deployment of pandemic supplies, including a foresight project to estimate needs for vaccines, antivirals, diagnostics and therapeutics. It also covers national deployment planning and support for sustainable influenza vaccine procurement and production.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-372197/blocks/prose-sec-009",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Influenza pandemic preparedness planning",
      "pageStart": 20,
      "pageEnd": 21,
      "target": "../sections/sec-009-influenza-pandemic-preparedness-planning.md",
      "narrative": null,
      "content": "BIENNIAL BUDGET:\nOUTPUT: National pandemic influenza preparedness & response plans are updated in the \ncontext of all-hazards preparedness and global health security\nIMPLEMENTED:\n$2M\n$430K\nMILESTONE\nHIGHLIGHTS\n•\tOf the 65 IPPP PC recipient countries in the \n2022-23 biennium, 37 (59%) now have a plan \nbased on WHO Guidance, of which five updated \ntheir plan in 2022. \n•\tCountries are developing their pandemic plans \nin a step-wise approach requiring consistent \nmulti-stakeholder engagement. Nine multi-\nsectoral planning workshops were conducted \nin six countries from three regions to assess \npre",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Reports progress on national pandemic influenza preparedness plans, noting that 37 of 65 funded countries have plans based on WHO guidance and that several held planning workshops or exercised their plans in 2022.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-372197/blocks/prose-sec-010",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "PIP Framework Secretariat",
      "pageStart": 21,
      "pageEnd": 23,
      "target": "../sections/sec-010-pip-framework-secretariat.md",
      "narrative": null,
      "content": "BIENNIAL BUDGET:\nOUTPUT: The PIP Secretariat leads, manages and supports implementation of the PIP Framework\nIMPLEMENTED:\n$5.9M\n$1.7M\nDELIVERABLE A\nDELIVERABLE B\nDELIVERABLE C\nIMPLEMENTED\n$834K\nIMPLEMENTED\n$245K\nIMPLEMENTED\n$600K\nPromote the effective \nimplementation of \nthe PIP Framework \nin a changing \nenvironment\nCollect, implement, \nmonitor, and report \non the Partnership \nContribution\nNegotiate and plan \nto operationalize the \nStandard Material \nTransfer Agreements \n2 (SMTA2)\nMILESTONES\nMILESTONES\nMILESTONES\nHIGHLIGHTS\nHIGHLIGHTS\nHIGHLIGHTS\nMeetings held and reports \nsubmitted to WHO DG o",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Reports on the work of the PIP Framework Secretariat in managing the Framework, including governance meetings and reports, collection and reporting of the Partnership Contribution, and negotiation of Standard Material Transfer Agreements 2 with manufacturers. Indicators show the share of contributions received in the year invoiced and the share of manufacturers with concluded agreements.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-372197/blocks/prose-sec-011",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Stories from the field",
      "pageStart": 23,
      "pageEnd": 31,
      "target": "../sections/sec-011-stories-from-the-field.md",
      "narrative": null,
      "content": "the field\nThe Global Influenza Surveillance & Response \nSystem at 70: a public health resource for the world \nGoing from strength to strength in the fight against influenza and other respiratory diseases.  \n\n\"Influenza is not a national issue; it’s not a national \nphenomenon – it’s a global phenomenon and you can’t \nwork on it isolated in the country.\"\n- Dr Olav Hungnes, Director of National Influenza Centre, \nNorwegian Institute of Public Health\n\nThe birth of GISRS\nIn 1952, the WHO Expert Committee on Influenza met \nand created a global network for influenza surveillance \nconsisting of WHO’s",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Presents stories from the field, beginning with the 70th anniversary of the Global Influenza Surveillance and Response System, which grew from a 1952 network into one spanning 127 countries, areas and territories. It describes the scale of testing by national influenza centres during the COVID-19 years and GISRS's role in providing viruses for vaccines. Country examples include Nepal's influenza centre taking on SARS-CoV-2 testing and the expansion of integrated surveillance under GISRS Plus. Other stories cover planning to monitor a future pandemic response and integrated respiratory surveillance in Timor-Leste.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-372197/blocks/figure-img-p024-1",
      "types": [
        "folio-assistant-core:Figure",
        "doco:Figure"
      ],
      "kind": "figure",
      "title": "",
      "pageStart": 24,
      "pageEnd": 24,
      "target": "../images/img-p024-1.webp",
      "narrative": "draft",
      "content": "A composite photograph for the GISRS 70th anniversary story. On the left, a gloved hand uses a pipette over sample tubes in a modern laboratory; on the right, in a circular black-and-white inset, two men in lab coats work at a bench with a tray of eggs.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/10665-372197/blocks/figure-img-p026-1",
      "types": [
        "folio-assistant-core:Figure",
        "doco:Figure"
      ],
      "kind": "figure",
      "title": "",
      "pageStart": 26,
      "pageEnd": 26,
      "target": "../images/img-p026-1.webp",
      "narrative": "draft",
      "content": "A node network diagram visualising emerging trends found in the literature, organised by the PESTLE framework. Six hub nodes labelled Law, Political, Social, Technological, Economic and Environment are linked to many small nodes, each a short headline-style trend (for example on COVAX, vaccine nationalism, mRNA vaccine hubs, artificial intelligence and climate change); most of the small labels are too small to read reliably.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/10665-372197/blocks/figure-img-p027-1",
      "types": [
        "folio-assistant-core:Figure",
        "doco:Figure"
      ],
      "kind": "figure",
      "title": "",
      "pageStart": 27,
      "pageEnd": 27,
      "target": "../images/img-p027-1.webp",
      "narrative": "draft",
      "content": "A photograph of a meeting room in which participants sit around tables with laptops, papers and refreshments while a man speaks at the head table in front of a projected slide and flags. The caption identifies it as the 2nd consultative workshop, Tabriz, Iran, 27 June 2022.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/10665-372197/blocks/figure-img-p029-1",
      "types": [
        "folio-assistant-core:Figure",
        "doco:Figure"
      ],
      "kind": "figure",
      "title": "",
      "pageStart": 29,
      "pageEnd": 29,
      "target": "../images/img-p029-1.webp",
      "narrative": "draft",
      "content": "A photograph in a hospital ward: a health worker wearing a face mask holds a folder and talks with a woman seated on a hospital bed, beside whom a young boy is standing. The caption describes surveillance activity at a sentinel site (HNGV) in Timor-Leste.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/10665-372197/blocks/figure-img-p029-2",
      "types": [
        "folio-assistant-core:Figure",
        "doco:Figure"
      ],
      "kind": "figure",
      "title": "",
      "pageStart": 29,
      "pageEnd": 29,
      "target": "../images/img-p029-2.webp",
      "narrative": "draft",
      "content": "A photograph of a health worker wearing a face mask and gloves who is placing a sample into a clear plastic specimen bag at a laboratory bench. The caption describes investigating and handling influenza samples at a sentinel site (HNGV) in Timor-Leste before sending them to the National Health Laboratory.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/10665-372197/blocks/prose-sec-012",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Annex: Financial report",
      "pageStart": 31,
      "pageEnd": 40,
      "target": "../sections/sec-012-annex-financial-report.md",
      "narrative": null,
      "content": "Financial report\nTable A.1: PIP Partnership Contribution received from each \nmanufacturer (2012 - 2022) \nStatus as of 31 December 2022\n\tCONTRIBUTORS\n TOTAL CONTRIBUTIONS (US$) \nSanofi Pasteur\n 65,841,037 \nGlaxosmithkline (GSK)\n 63,855,269 \nHoffmann - La Roche and Co. Ltd.\n 59,028,863 \nSeqirus\n 22,311,267 \nNovartis\n 15,292,743 \nMedimmune\n 10,062,070 \nKaketsuken (K M Biologics)\n 5,735,740 \nResearch Foundation for Microbial Disease of Osaka University (BIKEN)\n 5,721,067 \nDenka Seiken Co. Ltd.\n 4,033,848 \nKitasato Daiichi Sankyo Vaccine Co. Ltd.( Daiichi Sankyo Vaccine CO.Ltd.)\n 3,243,454 \nG C Pha",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The financial annex lists the Partnership Contribution received from each manufacturer between 2012 and 2022, led by Sanofi Pasteur, GSK and Roche, totalling about US$ 283 million. Further tables give 2022–2023 budgets, distributions, expenditure and balances for each output and deliverable, and for the secretariat and response funds. It ends with contact details for the PIP Framework Secretariat.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-372197/blocks/figure-img-p035-1",
      "types": [
        "folio-assistant-core:Figure",
        "doco:Figure"
      ],
      "kind": "figure",
      "title": "",
      "pageStart": 35,
      "pageEnd": 35,
      "target": "../images/img-p035-1.webp",
      "narrative": "draft",
      "content": "A handwritten signature in blue ink, preceded by \"pp.\" (signed on behalf of another person).",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/10665-372197/blocks/figure-img-p040-1",
      "types": [
        "folio-assistant-core:Figure",
        "doco:Figure"
      ],
      "kind": "figure",
      "title": "",
      "pageStart": 40,
      "pageEnd": 40,
      "target": "../images/img-p040-1.webp",
      "narrative": "draft",
      "content": "A barcode with the ISBN number 9789240076907.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    }
  ]
}
